Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| alpha 1-Antitrypsin | 4 | 2021 | 264 | 1.74 | Why? |
| Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 43 | 0.88 | Why? |
| NADPH Oxidase 2 | 1 | 2018 | 58 | 0.70 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.55 | Why? |
| Macrophages, Alveolar | 1 | 2018 | 668 | 0.53 | Why? |
| Prone Position | 2 | 2021 | 1861 | 0.47 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.46 | Why? |
| Integrin alphaVbeta3 | 2 | 2021 | 16 | 0.42 | Why? |
| Snake Venoms | 2 | 2021 | 29 | 0.41 | Why? |
| von Willebrand Factor | 3 | 2021 | 668 | 0.32 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.29 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.27 | Why? |
| Ireland | 3 | 2021 | 1456 | 0.22 | Why? |
| Acute-Phase Reaction | 1 | 2020 | 116 | 0.20 | Why? |
| Docosahexaenoic Acids | 1 | 2021 | 145 | 0.20 | Why? |
| Endothelial Cells | 2 | 2020 | 2048 | 0.19 | Why? |
| Occupational Injuries | 1 | 2021 | 148 | 0.19 | Why? |
| Thyroid Hormones | 1 | 2020 | 213 | 0.18 | Why? |
| Facial Injuries | 1 | 2021 | 173 | 0.18 | Why? |
| Erythrocyte Transfusion | 2 | 2019 | 386 | 0.18 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 291 | 0.17 | Why? |
| Coculture Techniques | 1 | 2018 | 258 | 0.17 | Why? |
| Lung | 3 | 2021 | 31049 | 0.17 | Why? |
| Lactic Acid | 1 | 2020 | 393 | 0.17 | Why? |
| Erythropoietin | 1 | 2019 | 167 | 0.17 | Why? |
| Catheterization, Swan-Ganz | 1 | 2016 | 30 | 0.17 | Why? |
| Carrier Proteins | 1 | 2020 | 513 | 0.16 | Why? |
| Protein Precursors | 1 | 2020 | 425 | 0.16 | Why? |
| Interleukin-10 | 2 | 2020 | 1409 | 0.16 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.15 | Why? |
| Wound Healing | 1 | 2020 | 424 | 0.15 | Why? |
| Macrophage Activation | 1 | 2018 | 315 | 0.15 | Why? |
| Anemia | 2 | 2019 | 789 | 0.14 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.14 | Why? |
| Umbilical Cord | 1 | 2017 | 358 | 0.14 | Why? |
| Interleukin-6 | 3 | 2021 | 7522 | 0.14 | Why? |
| Pressure Ulcer | 1 | 2020 | 398 | 0.13 | Why? |
| Iron | 1 | 2019 | 619 | 0.13 | Why? |
| Hemoglobins | 1 | 2019 | 958 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Cystic Fibrosis | 1 | 2020 | 1104 | 0.11 | Why? |
| Medical Staff, Hospital | 1 | 2021 | 1258 | 0.11 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.11 | Why? |
| Membrane Proteins | 1 | 2020 | 1733 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.10 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2021 | 10649 | 0.10 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.09 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 1322 | 0.09 | Why? |
| Hemodynamics | 1 | 2016 | 1562 | 0.09 | Why? |
| Immunologic Factors | 2 | 2021 | 4206 | 0.09 | Why? |
| Tracheostomy | 1 | 2020 | 1963 | 0.08 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.08 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.08 | Why? |
| Nursing Staff, Hospital | 1 | 2021 | 1554 | 0.08 | Why? |
| Humans | 25 | 2021 | 930598 | 0.08 | Why? |
| Cardiac Surgical Procedures | 1 | 2019 | 1931 | 0.07 | Why? |
| Monitoring, Physiologic | 1 | 2016 | 1956 | 0.07 | Why? |
| Animals | 3 | 2021 | 78931 | 0.07 | Why? |
| Thrombospondin 1 | 1 | 2021 | 29 | 0.06 | Why? |
| Cadherins | 1 | 2021 | 145 | 0.05 | Why? |
| Permeability | 1 | 2021 | 238 | 0.05 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 238 | 0.05 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.05 | Why? |
| Hematinics | 1 | 2019 | 48 | 0.05 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 229 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Blotting, Western | 1 | 2020 | 863 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2021 | 669 | 0.04 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.04 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2020 | 757 | 0.04 | Why? |
| Hospital Costs | 1 | 2020 | 274 | 0.04 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.04 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.04 | Why? |
| Phosphorylation | 1 | 2020 | 1060 | 0.04 | Why? |
| Capillary Permeability | 1 | 2018 | 277 | 0.04 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.04 | Why? |
| Tandem Mass Spectrometry | 1 | 2021 | 1031 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2020 | 992 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Interleukin-8 | 1 | 2020 | 964 | 0.03 | Why? |
| Adult | 9 | 2021 | 244371 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Male | 7 | 2021 | 367725 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Renal Insufficiency | 1 | 2019 | 810 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2016 | 11497 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Pulmonary Artery | 1 | 2016 | 803 | 0.02 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.02 | Why? |
| Female | 8 | 2021 | 380317 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.02 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Hypoxia | 1 | 2019 | 3626 | 0.02 | Why? |
| Surgical Procedures, Operative | 1 | 2019 | 2662 | 0.02 | Why? |
| Myocardial Infarction | 1 | 2019 | 3361 | 0.02 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Masks | 1 | 2021 | 8528 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.01 | Why? |
| Stroke | 1 | 2019 | 8839 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
Curley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(146)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(160)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_